Healthcare Services

Visceral Pain Market Forecast Showing Industry Progress and Expansion Trends

April 28, 2026April 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Visceral Pain Market In 2026 And 2030?

The visceral pain market has experienced robust growth over recent years. Projections indicate its value will rise from $14.82 billion in 2025 to $15.7 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 5.9%. Historically, this expansion has been driven by factors such as the rising incidence of gastrointestinal and pelvic disorders, broader application of NSAIDs and calcium channel blockers, enhanced clinical identification of visceral pain conditions, the proliferation of hospital-based pain management services, and the introduction of various drug classes.

The visceral pain market is anticipated to experience robust expansion over the coming years. This market is projected to reach $19.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.7%. Factors contributing to this growth during the forecast period include a heightened demand for tailored pain treatments, an increased emphasis on managing chronic pain, the wider application of precision medicine strategies, the greater integration of sophisticated diagnostic instruments, and augmented funding for non-opioid drug innovation. Key trends anticipated for the forecast period encompass a broader embrace of targeted pain management solutions, an escalating utilization of multi-drug regimens, a reinforced commitment to non-opioid therapeutic alternatives, the broadening scope of individualized visceral pain management, and a stronger focus on prompt diagnosis and intervention.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13950&type=smp

What Key Drivers Are Fueling The Growth Of The Visceral Pain Market?

The increasing need for pain-relieving medications, known as analgesics, is anticipated to propel the expansion of the visceral pain market in the future. Analgesics are drugs designed to alleviate pain by reducing or blocking the brain’s perception of pain signals. They help control visceral pain by targeting the nervous system and modulating signals that originate from internal organs. For instance, an April 2024 report in the New England Journal of Medicine, a UK-based weekly medical journal, noted that over 53,600 clinicians were prescribing buprenorphine by December 2023. This figure demonstrates an increase of 11,500 prescribers compared to December 2022. Thus, the escalating demand for analgesics is a key factor driving the growth of the visceral pain market.

How Are Different Segments Classified In The Visceral Pain Market Segment Analysis?

The visceral pain market covered in this report is segmented –

1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes

2) By Indications: Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications

3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Calcium Channel Blockers: Dihydropyridines, Non-Dihydropyridines

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAID): Selective COX-2 Inhibitors, Non-Selective NSAIDs

3) By Other Drug Classes: Opioids, Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

What Trends Are Influencing The Visceral Pain Market?

Leading companies in the chronic pain market are increasingly concentrating on clinical trials to develop innovative products, such as NOP receptor agonists, aiming to provide effective pain relief while potentially reducing the risks associated with opioid-based treatments. NOP receptor agonists are compounds that activate the nociceptin/orphanin FQ peptide receptor, modulating pain signaling in the nervous system. They offer benefits by alleviating chronic and visceral pain without the high risk of addiction or severe side effects typically linked to traditional opioids. For example, in October 2024, Grünenthal GmbH, a pharmaceutical company based in Germany, initiated a first-in-human Phase I clinical trial with 90 healthy participants to evaluate the safety, tolerability, and pharmacokinetics of its novel NOP receptor agonist. This study aims to assess the investigational compound’s potential to deliver potent and safe pain relief across various chronic pain conditions, proposing a novel therapeutic approach for managing both somatic and visceral pain.

Who Are The Companies Driving Activity In The Visceral Pain Market?

Major companies operating in the visceral pain market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd.

Get The Full Visceral Pain Market Report:

https://www.thebusinessresearchcompany.com/report/visceral-pain-global-market-report

Which Geographic Region Dominates The Visceral Pain Market?

North America was the largest region in the visceral pain market in 2025. The regions covered in the visceral pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Visceral Pain Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/visceral-pain-global-market-report

Browse Through More Reports Similar to the Global Visceral Pain Market 2026, By The Business Research Company

Chronic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Neuropathic Pain Market Report

https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

Ulcerative Colitis Market Report

https://www.thebusinessresearchcompany.com/report/ulcerative-colitis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795